companydata.dkBIOMOTION PHARMA ApS: Financial statements 2012
CVR: 12928203
BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,550 and a net result of DKK 2,550. Equity amounted to DKK -1,000.
- Gross Profit
- 2,550 kr.
- Profit/Loss
- 2,550 kr.
- Equity
- -1,000 kr.
- Total Assets
- 0 kr.
How creditworthy is BIOMOTION PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of October 15, 2012, Lennie Rasmussen has stepped down as director of BIOMOTION PHARMA ApS.
As of October 15, 2012, Michael Rasmussen is registered as an owner of BIOMOTION PHARMA ApS with an ownership share of 100%.
As of March 28, 2012, JUT NR. 2180 A/S has been appointed auditor of BIOMOTION PHARMA ApS.
As of March 28, 2012, EY Danmark A/S has stepped down as auditor of BIOMOTION PHARMA ApS.
About BIOMOTION PHARMA ApS
BIOMOTION PHARMA ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Henrik Selchau Poulsen. The company is owned by Michael Rasmussen. In 2024, the company reported a gross profit of DKK -5,313 and a net result of DKK -6,460 compared with DKK -1,430 the year before. Equity amounted to DKK 3,310.